Eurazeo: increases stake in Kurma Partners
(CercleFinance.com) - Eurazeo announces that it is increasing its stake in Kurma Partners - a management company specialising in biotech and medical innovation - to 70.
6%. This transaction coincides with Kurma Partners' launch of a third investment strategy.
Dubbed 'Growth Opportunity', this new strategy aims to fund the more mature companies in the later stages of their pre-marketing development. Eurazeo will be an investor of reference in this strategy.
Eurazeo plans to deploy close to 100 million euros in these funds. It will also offer its operational support and access to its international network to make Kurma Partners one of the European leaders in the field of medical innovation.
Copyright (c) 2021 CercleFinance.com. All rights reserved.
6%. This transaction coincides with Kurma Partners' launch of a third investment strategy.
Dubbed 'Growth Opportunity', this new strategy aims to fund the more mature companies in the later stages of their pre-marketing development. Eurazeo will be an investor of reference in this strategy.
Eurazeo plans to deploy close to 100 million euros in these funds. It will also offer its operational support and access to its international network to make Kurma Partners one of the European leaders in the field of medical innovation.
Copyright (c) 2021 CercleFinance.com. All rights reserved.